Tag: virtual trials

Global Implementation Models for Inclusivity & Rural Access Across US, EU and UK Global Implementation Models for Inclusivity & Rural Access Across US, EU and UK Introduction to Inclusivity in Clinical Trials In recent years, the importance of inclusivity in clinical trials has gained widespread recognition among clinical operations, regulatory affairs, and medical affairs professionals….

Read More “Global Implementation Models for Inclusivity & Rural Access Across US, EU and UK” »

Future Trends: Hybrid, Virtual and Platform-Enabled Inclusivity & Rural Access Future Trends: Hybrid, Virtual and Platform-Enabled Inclusivity & Rural Access Understanding the Landscape of Decentralized Clinical Trials Decentralized clinical trials (DCTs) have gained significant traction due to the rise of technology and the need for more inclusive clinical research methodologies. In essence, a decentralized clinical…

Read More “Future Trends: Hybrid, Virtual and Platform-Enabled Inclusivity & Rural Access” »

Digital Tools and Platforms Required to Enable Inclusivity & Rural Access Digital Tools and Platforms Required to Enable Inclusivity & Rural Access As the clinical research landscape evolves, there is an increasing need for inclusivity, particularly for rural populations. This guide serves as a comprehensive tutorial for clinical operations, regulatory affairs, and medical affairs professionals…

Read More “Digital Tools and Platforms Required to Enable Inclusivity & Rural Access” »

Workflow and SOP Design to Operationalize Inclusivity & Rural Access at Scale The increasing complexity of clinical trials necessitates a robust approach to inclusivity and rural access. As decentralized clinical trials (DCTs) evolve, the need for effective workflows and standard operating procedures (SOPs) becomes paramount. This article serves as a comprehensive, step-by-step tutorial for clinical…

Read More “Workflow and SOP Design to Operationalize Inclusivity & Rural Access at Scale” »

KRIs, KPIs and Dashboards to Monitor Inclusivity & Rural Access Performance In the context of decentralized and hybrid clinical trials, the need for effective monitoring metrics has never been more critical. Key Risk Indicators (KRIs), Key Performance Indicators (KPIs), and dashboards play an essential role in ensuring that clinical trials, such as the donanemab clinical…

Read More “KRIs, KPIs and Dashboards to Monitor Inclusivity & Rural Access Performance” »

Case Studies: Inclusivity & Rural Access That Improved Recruitment and Retention Case Studies: Inclusivity & Rural Access That Improved Recruitment and Retention Introduction to Clinical Trial Inclusivity and Rural Access The landscape of clinical trials has been evolving, driven by the need for diverse participant representation and enhanced recruitment and retention strategies. In regions where…

Read More “Case Studies: Inclusivity & Rural Access That Improved Recruitment and Retention” »

Patient-Centric Design Principles for Successful Inclusivity & Rural Access Patient-Centric Design Principles for Successful Inclusivity & Rural Access The landscape of clinical trials is rapidly evolving, particularly with the advent of decentralized and hybrid clinical trials. As clinical research professionals, ensuring inclusivity and accessibility for all participants, particularly those in rural areas, is intrinsic to…

Read More “Patient-Centric Design Principles for Successful Inclusivity & Rural Access” »

Inclusivity & Rural Access: Operating Blueprint for Scalable Decentralized Trials Decentralized clinical trials (DCTs) have emerged as a transformative approach that seeks to enhance inclusivity and access to clinical research, particularly for underserved rural populations. This article serves as a comprehensive guide for clinical research professionals to develop strategies that enable the effective implementation of…

Read More “Inclusivity & Rural Access: Operating Blueprint for Scalable Decentralized Trials” »

How to Design Inclusivity & Rural Access That Meets FDA, EMA and MHRA Expectations How to Design Inclusivity & Rural Access That Meets FDA, EMA and MHRA Expectations As clinical trials continue to evolve, there is an increasing emphasis on inclusivity and access to rural populations. This article will provide a comprehensive, step-by-step guide designed…

Read More “How to Design Inclusivity & Rural Access That Meets FDA, EMA and MHRA Expectations” »

Inclusivity & Rural Access in Practice: Step-by-Step Guide for Sponsors and CROs Introduction Decentralized and hybrid clinical trials (DCTs) have emerged as pivotal methodologies for enhancing patient inclusivity, particularly in rural areas. As clinical research organization companies continue to adapt to the shifting landscape of clinical trials, the integration of these innovative approaches is paramount…

Read More “Inclusivity & Rural Access in Practice: Step-by-Step Guide for Sponsors and CROs” »